My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 244

    1.

    Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.

    Westermann D, Rutschow S, Jäger S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschöpe C.

    Diabetes. 2007 Mar;56(3):641-6.PMID: 17327431 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.

    Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C.

    Basic Res Cardiol. 2008 Jul;103(4):319-27. Epub 2008 Mar 17.PMID: 18347835 [PubMed - indexed for MEDLINE]Related articles

    3.

    Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.

    Tsutsui H, Matsushima S, Kinugawa S, Ide T, Inoue N, Ohta Y, Yokota T, Hamaguchi S, Sunagawa K.

    Hypertens Res. 2007 May;30(5):439-49.PMID: 17587756 [PubMed - indexed for MEDLINE]Related articles

    4.

    Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

    Westermann D, Rutschow S, Van Linthout S, Linderer A, Bücker-Gärtner C, Sobirey M, Riad A, Pauschinger M, Schultheiss HP, Tschöpe C.

    Diabetologia. 2006 Oct;49(10):2507-13. Epub 2006 Aug 26.PMID: 16937126 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.

    Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschöpe C.

    Basic Res Cardiol. 2007 Nov;102(6):500-7. Epub 2007 Oct 5.PMID: 17909696 [PubMed - indexed for MEDLINE]Related articles

    6.

    Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.

    Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, Scholey JW, Penninger JM, Oudit GY.

    Circ Heart Fail. 2009 Sep;2(5):446-55. Epub 2009 Jun 15.PMID: 19808375 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan.

    Dixon IM, Ju H, Reid NL, Scammell-La Fleur T, Werner JP, Jasmin G.

    J Mol Cell Cardiol. 1997 Jul;29(7):1837-50.PMID: 9236138 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.

    Anjaneyulu M, Chopra K.

    Am J Nephrol. 2004 Sep-Oct;24(5):488-96. Epub 2004 Sep 7.PMID: 15353911 [PubMed - indexed for MEDLINE]Related articles

    9.

    Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.

    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.

    Cardiovasc Res. 2005 Jul 1;67(1):97-105. Epub 2005 Apr 7.PMID: 15949473 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

    Westermann D, Walther T, Savvatis K, Escher F, Sobirey M, Riad A, Bader M, Schultheiss HP, Tschöpe C.

    Diabetes. 2009 Jun;58(6):1373-81. Epub 2009 Mar 10.PMID: 19276445 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.

    Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Esaki M, Kanamori H, Li L, Ogino A, Ohno T, Kondo T, Nakagawa M, Minatoguchi S, Fujiwara T, Fujiwara H.

    J Card Fail. 2007 Mar;13(2):155-62.PMID: 17395057 [PubMed - indexed for MEDLINE]Related articles

    12.

    Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.

    Funabiki K, Onishi K, Dohi K, Koji T, Imanaka-Yoshida K, Ito M, Wada H, Isaka N, Nobori T, Nakano T.

    Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2487-92.PMID: 15548724 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs.

    Lu L, Zhang Q, Pu LJ, Peng WH, Yan XX, Wang LJ, Chen QJ, Zhu ZB, Michel JB, Shen WF.

    Int J Exp Pathol. 2008 Apr;89(2):125-37.PMID: 18336530 [PubMed - indexed for MEDLINE]Related articles

    14.

    Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.

    Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A.

    Circulation. 2004 Mar 30;109(12):1482-8. Epub 2004 Mar 22.PMID: 15037537 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart.

    Hayashi T, Sohmiya K, Ukimura A, Endoh S, Mori T, Shimomura H, Okabe M, Terasaki F, Kitaura Y.

    Heart. 2003 Oct;89(10):1236-42.PMID: 12975429 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.

    Seccia TM, Belloni AS, Kreutz R, Paul M, Nussdorfer GG, Pessina AC, Rossi GP.

    J Am Coll Cardiol. 2003 Feb 19;41(4):666-73.PMID: 12598081 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.

    Jin D, Takai S, Sugiyama T, Hayashi T, Fukumoto M, Oku H, Kitaura Y, Ikeda T, Miyazaki M.

    J Pharmacol Sci. 2009 Feb;109(2):275-84. Epub 2009 Feb 7.PMID: 19202318 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats.

    Jesmin S, Sakuma I, Hattori Y, Kitabatake A.

    Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2021-6. Epub 2003 Sep 4.PMID: 12958045 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.

    Tschöpe C, Walther T, Königer J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M.

    FASEB J. 2004 May;18(7):828-35.PMID: 15117887 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.

    Yamamoto K, Mano T, Yoshida J, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Hori M, Miwa T, Masuyama T.

    J Hypertens. 2005 Feb;23(2):393-400.PMID: 15662228 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity